top of page

REPOSE

REPOTRECTINIB IN ROS1-POSITIVE NON-SMALL CELL LUNG CANCER PATIENTS WITH ACTIVE BRAIN METASTASIS

TRIAL RESUME

home_fondo_you_barra.jpg
REPOSE.png

CLINICAL TRIAL DETAILS

A PHASE II STUDY ASSESSING SAFETY AND EFFICACY OF REPOTRECTINIB IN ROS1-POSITIVE NON-SMALL CELL LUNG CANCER PATIENTS WITH ACTIVE BRAIN METASTASIS (REPOSE STUDY)

 
REPOSE AT CLINICALTRIALS.GOV

TUMOR TYPE

PHASE

nsclc BMs

II

20

TBC

TBC

Study Start Up

N

SITES

COUNTRY

STATUS

bottom of page